Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 29, 2023 (Week 30)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 15,331 33,654 788,526 943,139
New England 186 1,471 23,248 29,175
Connecticut - 251 1,156 6,071
Maine 66 77 1,684 1,842
Massachusetts - 709 15,463 16,050
New Hampshire - 82 1,339 1,758
Rhode Island 102 694 2,817 2,735
Vermont 18 37 789 719
Middle Atlantic 2,900 4,218 111,220 110,170
New Jersey 450 788 19,465 19,051
New York (excluding New York City) 921 1,032 23,510 22,522
New York City 705 1,457 37,450 36,995
Pennsylvania 824 1,233 30,795 31,602
East North Central 1,925 5,878 108,211 163,174
Illinois 122 1,811 28,492 40,775
Indiana 322 858 16,434 19,134
Michigan 376 975 18,371 24,417
Ohio 703 2,294 30,646 63,816
Wisconsin 402 561 14,268 15,032
West North Central 802 2,166 52,980 58,391
Iowa 157 334 7,753 8,513
Kansas 68 337 5,722 8,137
Minnesota 107 496 12,290 12,797
Missouri 420 729 17,769 18,372
Nebraska - 220 4,902 5,561
North Dakota - 92 1,759 2,059
South Dakota 50 125 2,785 2,952
South Atlantic 3,160 7,251 172,870 197,118
Delaware 80 420 3,260 5,968
District of Columbia - 191 3,996 4,697
Florida 1,754 2,787 62,539 60,774
Georgia - 1,596 25,991 42,006
Maryland U NC U U
North Carolina 14 1,439 31,763 37,627
South Carolina 592 884 18,994 20,747
Virginia 702 976 23,933 22,688
West Virginia 18 104 2,394 2,611
East South Central 1,733 2,505 48,612 64,172
Alabama 836 972 19,910 17,662
Kentucky 555 425 9,259 10,410
Mississippi 108 529 344 13,710
Tennessee 234 1,094 19,099 22,390
West South Central 654 5,295 81,860 145,625
Arkansas 194 804 9,060 20,703
Louisiana 406 794 19,919 21,136
Oklahoma 54 422 6,141 11,326
Texas - 3,398 46,740 92,460
Mountain 1,041 2,523 58,443 67,657
Arizona 453 918 22,547 23,697
Colorado - 651 14,100 14,805
Idaho 112 155 3,301 3,226
Montana 50 112 1,616 2,419
Nevada 204 367 4,441 9,591
New Mexico 18 257 5,167 6,483
Utah 185 249 6,364 6,454
Wyoming 19 54 907 982
Pacific 2,930 5,047 131,082 107,657
Alaska 43 121 2,229 3,059
California 2,126 4,112 108,745 75,267
Hawaii - 142 - 3,164
Oregon 311 362 8,682 9,117
Washington 450 635 11,426 17,050
U.S. Territories - 124 1,138 2,737
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 2,737
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 7 34 80
Total 15,332 33,754 789,698 945,956
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.